Marvin A. Brooks

1.7k total citations
57 papers, 1.4k citations indexed

About

Marvin A. Brooks is a scholar working on Spectroscopy, Analytical Chemistry and Biomedical Engineering. According to data from OpenAlex, Marvin A. Brooks has authored 57 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Spectroscopy, 24 papers in Analytical Chemistry and 10 papers in Biomedical Engineering. Recurrent topics in Marvin A. Brooks's work include Analytical Chemistry and Chromatography (23 papers), Analytical Methods in Pharmaceuticals (23 papers) and Antibiotics Pharmacokinetics and Efficacy (9 papers). Marvin A. Brooks is often cited by papers focused on Analytical Chemistry and Chromatography (23 papers), Analytical Methods in Pharmaceuticals (23 papers) and Antibiotics Pharmacokinetics and Efficacy (9 papers). Marvin A. Brooks collaborates with scholars based in United States and Switzerland. Marvin A. Brooks's co-authors include Martin R. Hackman, Dominic P. Ip, Eric W. Tsai, Carl V. Puglisi, Robert E. Weinfeld, Ihor Bekersky, S. A. Kaplan, Mia Parsonnet, Indravadan H. Patel and Qingxi Wang and has published in prestigious journals such as Analytical Chemistry, Antimicrobial Agents and Chemotherapy and Journal of Chromatography A.

In The Last Decade

Marvin A. Brooks

56 papers receiving 1.3k citations

Peers

Marvin A. Brooks
B Widdop United Kingdom
J.H. Perrin United States
I.L. Honigberg United States
Kees Ensing Netherlands
B Widdop United Kingdom
Marvin A. Brooks
Citations per year, relative to Marvin A. Brooks Marvin A. Brooks (= 1×) peers B Widdop

Countries citing papers authored by Marvin A. Brooks

Since Specialization
Citations

This map shows the geographic impact of Marvin A. Brooks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marvin A. Brooks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marvin A. Brooks more than expected).

Fields of papers citing papers by Marvin A. Brooks

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marvin A. Brooks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marvin A. Brooks. The network helps show where Marvin A. Brooks may publish in the future.

Co-authorship network of co-authors of Marvin A. Brooks

This figure shows the co-authorship network connecting the top 25 collaborators of Marvin A. Brooks. A scholar is included among the top collaborators of Marvin A. Brooks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marvin A. Brooks. Marvin A. Brooks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Abend, Andreas, et al.. (2004). Concerning the stability of benzyl alcohol: formation of benzaldehyde dibenzyl acetal under aerobic conditions. Journal of Pharmaceutical and Biomedical Analysis. 34(5). 957–962. 21 indexed citations
2.
Wang, Qingxi, et al.. (1998). Determination of losartan and its degradates in COZAAR® tablets by reversed-phase high-performance thin-layer chromatography. Journal of Pharmaceutical and Biomedical Analysis. 17(4-5). 671–677. 78 indexed citations
3.
Bruner, Mark W., J. Goldstein, C. Russell Middaugh, Marvin A. Brooks, & David B. Volkin. (1997). Size exclusion HPLC method for the determination of acidic fibroblast growth factor in viscous formulations. Journal of Pharmaceutical and Biomedical Analysis. 15(12). 1929–1935. 6 indexed citations
4.
Martin, Gregory P., et al.. (1995). The determination of alendronate sodium in tablets by inductively coupled plasma (ICP). Journal of Pharmaceutical and Biomedical Analysis. 13(8). 1055–1058. 17 indexed citations
5.
Ip, Dominic P., et al.. (1994). Use of Supercritical Fluid Extraction for Sample Preparation of Sustained‐Release Felodipine Tablets. Journal of Pharmaceutical Sciences. 83(11). 1537–1542. 21 indexed citations
6.
Taylor, Larry T., et al.. (1994). Analysis of felodipine by packed column supercritical fluid chromatography with electron capture and ultraviolet absorbance detection. Journal of Pharmaceutical and Biomedical Analysis. 12(8). 1003–1014. 29 indexed citations
7.
Tsai, Eric W., et al.. (1994). Determination of bisphosphonate drugs in pharmaceutical dosage formulations by ion chromatography with indirect UV detection. Journal of Pharmaceutical and Biomedical Analysis. 12(8). 983–991. 45 indexed citations
8.
Qin, Xue‐Zhi, et al.. (1994). Pharmaceutical application of LC-MS. 1 — Characterization of a famotidine degradates in a package screening study by LC-APCI MS. Journal of Pharmaceutical and Biomedical Analysis. 12(2). 221–233. 33 indexed citations
9.
Tsai, Eric W., Dominic P. Ip, & Marvin A. Brooks. (1993). Determination of etidronate disodium tablets by ion chromatography with indirect UV detection. Journal of Pharmaceutical and Biomedical Analysis. 11(6). 513–516. 15 indexed citations
10.
Tsai, Eric W., Dominic P. Ip, & Marvin A. Brooks. (1992). Determination of alendronate in pharmaceutical dosage formulations by ion chromatography with conductivity detection. Journal of Chromatography A. 596(2). 217–224. 53 indexed citations
11.
Tsai, Eric W., et al.. (1992). Application of capillary electrophoresis to pharmaceutical analysis. Journal of Chromatography A. 626(2). 245–250. 48 indexed citations
12.
Ryan, James A., et al.. (1991). Rapid verification of identity and content of drug formulations using mid-infrared spectroscopy. Journal of Pharmaceutical and Biomedical Analysis. 9(4). 303–310. 23 indexed citations
13.
Brooks, Marvin A., et al.. (1989). The determination of 4-amino-1-hydroxybutane-1,1-diphosphonic acid monosodium salt trihydrate in pharmaceutical dosage forms by high-performance liquid chromatography. Journal of Pharmaceutical and Biomedical Analysis. 7(12). 1719–1727. 38 indexed citations
14.
Brooks, Marvin A., et al.. (1988). A flow injection system with in-series ultraviolet and electrochemical detection for the simultaneous determination of lovastatin and butylated hydroxyanisole in a tablet. Journal of Pharmaceutical and Biomedical Analysis. 6(3). 271–276. 4 indexed citations
15.
Brooks, Marvin A., et al.. (1985). Determination of 4-amino-5-ethyl-3-thiophenecarboxylic acid methyl ester and its acid metabolite in plasma and urine by high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 345(2). 333–343. 1 indexed citations
16.
Brooks, Marvin A. & Robert E. Weinfeld. (1985). A Validation Process for Data from the Analysis of Drugs in Biological Fluids. Drug Development and Industrial Pharmacy. 11(9-10). 1703–1728. 7 indexed citations
17.
Brooks, Marvin A., et al.. (1982). Determination of bromo-lasalocid in plasma by high-performance liquid chromatography with fluorimetric detection. Journal of Chromatography B Biomedical Sciences and Applications. 229(1). 167–178. 1 indexed citations
18.
Patel, Indravadan H., et al.. (1981). Pharmacokinetics of ceftriaxone in humans. Antimicrobial Agents and Chemotherapy. 20(5). 634–641. 207 indexed citations
19.
Brooks, Marvin A., et al.. (1975). Determination of 1,4-benzodiazepines in biological fluids by differential pulse polarography. Talanta. 22(10-11). 849–860. 39 indexed citations
20.
Hackman, Martin R., et al.. (1975). Organic functional group analysis at the micromole level. I. Microchimica Acta. 64(6). 617–625. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026